The contributions of resistin and adiponectin gene single nucleotide polymorphisms to the genetic risk for polycystic ovary syndrome in a Japanese population

References

• Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853–861
   PubMed Web of Science ®Google Scholar
• Knochenhauer E S, Key T J, Kahsar-Miller M, Waggoner W, Boots L R, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J Clin Endocrinol Metab 1998; 83: 3078–3082
   PubMed Web of Science ®Google Scholar
• Futterweit W. Polycystic ovary syndrome: Clinical perspectives and management. Obstet Gynecol Surv 1999; 54: 403–413
   PubMedGoogle Scholar
• The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41–47
   PubMed Web of Science ®Google Scholar
• Dunaif A, Segal K R, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38: 1165–1174
   PubMed Web of Science ®Google Scholar
• Barbieri R L, Smith S, Ryan K J. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril 1988; 50: 197–212
   PubMed Web of Science ®Google Scholar
• DeFronzo R A, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173–194
   PubMed Web of Science ®Google Scholar
• Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002; 51: 536–540
   PubMed Web of Science ®Google Scholar
• Steppan C M, Bailey S T, Bhat S, Brown E J, Banerjee R R, Wright C M, Patel H R, Ahima R S, Lazar M A. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307–312
   PubMed Web of Science ®Google Scholar
• Gibson F, Froguel P. Genetics of the ADIPOQ locus and its contribution to type 2 diabetes susceptibility in French Caucasians. Diabetes 2004; 53: 2977–2983
   PubMed Web of Science ®Google Scholar
• Osawa H, Yamada K, Onuma H, Murakami A, Ochi M, Kawata H, Nishimiya T, Niiya T, Shimizu I, Nishida W, et al. The G/G genotype of a resistin single-nucleotide polymorphism at −420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet 2004; 75: 678–686
   PubMed Web of Science ®Google Scholar
• Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419
   PubMed Web of Science ®Google Scholar
• Bonora E, Targher G, Alberiche M, Bonadonna R C, Saggiani F, Zenere M B, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57–63
   PubMed Web of Science ®Google Scholar
• Yokoyama H, Hirose H, Ohgo H, Saito I. Association among lifestyle status, serum adiponectin level and insulin resistance. Intern Med 2004; 43: 453–457
   PubMed Web of Science ®Google Scholar
• Grigorescu M, Radu C, Crisan D, Grigorescu M D, Serban A, Neculoiu D, Rusu M, Acalovschi M. Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C. J Gastrointestin Liver Dis 2008; 17: 147–154
   PubMed Web of Science ®Google Scholar
• Livak K J. Allelic discrimination using fluorogenic probes and the 5’ nuclease assay. Genet Anal 1999; 14: 143–149
   PubMedGoogle Scholar
• Maeda K, Okubo K, Shimomura I, Mizuno K, Matsuzawa Y, Matsubara K. Analysis of an expression profile of genes in the human adipose tissue. Gene 1997; 190: 227–235
   PubMed Web of Science ®Google Scholar
• Rangwala S M, Rich A S, Rhoades B, Shapiro J S, Obici S, Rossetti L, Lazar M A. Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 2004; 53: 1937–1941
   PubMed Web of Science ®Google Scholar
• Steppan C M, Wang J, Whiteman E L, Birnbaum M J, Lazar M A. Activation of SOCS-3 by resistin. Mol Cell Biol 2005; 25: 1569–1575
   PubMed Web of Science ®Google Scholar
• Urbanek M, Du Y, Silander K, Collins F S, Steppan C M, Strauss J F, 3rd, Dunaif A, Spielman R S, Legro R S. Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes 2003; 52: 214–217
   PubMed Web of Science ®Google Scholar
• Xita N, Georgiou I, Tsatsoulis A, Kourtis A, Kukuvitis A, Panidis D. A polymorphism in the resistin gene promoter is associated with body mass index in women with polycystic ovary syndrome. Fertil Steril 2004; 82: 1466–1467
   PubMed Web of Science ®Google Scholar
• Engert J C, Vohl M C, Williams S M, Lepage P, Loredo-Osti J C, Faith J, Dore C, Renaud Y, Burtt N P, Villeneuve A, et al. 5′ flanking variants of resistin are associated with obesity. Diabetes 2002; 51: 1629–1634
   PubMed Web of Science ®Google Scholar
• Ma X, Warram J H, Trischitta V, Doria A. Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. J Clin Endocrinol Metab 2002; 87: 4407–4410
   PubMed Web of Science ®Google Scholar
• Perez-Martınez P, Perez-Jimenez F, Bellido C, Ordovas J M, Moreno J A, Marın C, Gomez P, Delgado-Lista J, Fuentes F, Lopez-Miranda J. A Polymorphism exon 1 variant at the locus of the scavenger receptor class B type I (SCARB1) gene is associated with differences in insulin sensitivity in healthy people during the consumption of an olive oil-rich diet. J Clin Endocrinol Metab 2005; 90: 2297–2300
   PubMed Web of Science ®Google Scholar
• Huber-Buchholz M M, Carey D G, Norman R J. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: Role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 1999; 84: 1470–1474
   PubMed Web of Science ®Google Scholar
• Conneely K N, Silander K, Scott L J, Mohlke K L, Lazaridis K N, Valle T T, Tuomilehto J, Bergman R N, Watanabe R M, Buchanan T A, et al. Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 2004; 47: 1782–1788
   PubMed Web of Science ®Google Scholar
• Panidis D, Kourtis A, Kukuvitis A, Farmakiotis D, Xita N, Georgiou I, Tsatsoulis A. Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: Role of Delta4-androstenedione. Hum Reprod 2004; 19: 1728–1733
   PubMed Web of Science ®Google Scholar
• Haap M, Machicao F, Stefan N, Thamer C, Tschritter O, Schnuck F, Wallwiener D, Stumvoll M, Haring H U, Fritsche A. Genetic determinants of insulin action in polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2005; 113: 275–281
   PubMed Web of Science ®Google Scholar
• Heinonen S, Korhonen S, Helisalmi S, Koivunen R, Tapanainen J, Hippelainen M, Laakso M. Associations between two single nucleotide polymorphisms in the adiponectin gene and polycystic ovary syndrome. Gynecol Endocrinol 2005; 21: 165–169
   PubMed Web of Science ®Google Scholar
• Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, Boutin P, Vaxillaire M, Lepretre F, Dupont S, et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the ADIPOQ gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002; 11: 2607–2614
   PubMed Web of Science ®Google Scholar
• Heid I M, Wagner S A, Gohlke H, Iglseder B, Mueller J C, Cip P, Ladurner G, Reiter R, Stadlmayr A, Mackevics V. Genetic architecture of the ADIPOQ gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 2006; 55: 375–384
   PubMed Web of Science ®Google Scholar